Inotiv partners with cardiovascular researchers, offering comprehensive, cutting-edge solutions for drug discovery and development, from intricacies of the system to clinical success.
Welcome to Inotiv’s cutting-edge cardiovascular solutions for drug discovery and development, where science meets innovation to redefine the “contract to discover partnership” with cardiovascular researchers and developers. Tailored to ensure the success of your therapeutic program, we integrate state-of-the-art methodologies to unravel the intricacies of the human cardiovascular system and assess the efficacy and safety for groundbreaking advancements in pharmaceuticals. By leveraging advanced disease pharmacology models while integrating molecular and cell sciences, molecular pathology, and proteogenomic capabilities, we offer you a comprehensive approach with unparalleled insights into the mechanism of therapeutic intervention, the safety of novel therapies, and the predicted clinical success of our client’s drug programs.
Define research goals and select the best CRO partner.
Develop a detailed study protocol with the chosen CRO.
Select and activate pre-clinical research sites with the CRO's expertise.
Transparently partner with the CRO to monitor progress in order to make study optimizations.
Collect, analyze data, and provide comprehensive study reports.
A Driver of Cardiovascular and Renal Disease
Watch On-demand Webinar Watch On-demand WebinarAdvancing Cardiovascular Research with Surgical Models
Download Article Download ArticleBrowse Our Sprague Dawley® Rat Reference Resources Today
Request a Sample Request a Sample
Copyright © 2024 Inotiv. All Rights Reserved.